Clinical trials
Completed Phase 1/2 trials in Mexico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 2 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 4 |
| 2012 | 5 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 41 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 4 |
| Coordinación de Investigación en Salud, Mexico | 2 |
| Eli Lilly and Company | 2 |
| GlaxoSmithKline | 2 |
| Hospital Universitario Dr. Jose E. Gonzalez | 2 |
| Sanofi | 2 |
| University of Guadalajara | 2 |
| Allegro Ophthalmics, LLC | 1 |
| Antiva Biosciences | 1 |
| Ascentia Health, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 3 |
| COVID-19 | 3 |
| Cytokine Release Syndrome | 2 |
| Lupus Erythematosus, Systemic | 2 |
| Respiratory Syncytial Virus Infections | 2 |
| Adenocarcinoma | 1 |
| Amnesia | 1 |
| Arthritis, Rheumatoid | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Carcinoma, Renal Cell | 1 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.